pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-181b-1 |
Genomic Coordinates | chr1: 137966639 - 137966718 |
Description | Mus musculus miR-181b-1 stem-loop |
Comment | Mouse miR-181b was predicted by computational methods using conservation with human and Fugu rubripes sequences . |
RNA Secondary Structure | |
pre-miRNA | mmu-mir-181b-2 |
Genomic Coordinates | chr2: 38853830 - 38853918 |
Synonyms | Mirn181b-2, mir-181b-2, Mir181b-2 |
Description | Mus musculus miR-181b-2 stem-loop |
Comment | Mouse miR-181b was predicted by computational methods using conservation with human and Fugu rubripes sequences . |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-181b-5p |
Sequence | 12| AACAUUCAUUGCUGUCGGUGGGU |34 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Stk32a | ||||||||||||||||||||
Synonyms | A930015B13Rik, YANK1 | ||||||||||||||||||||
Description | serine/threonine kinase 32A | ||||||||||||||||||||
Transcript | NM_178749 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Stk32a | |||||||||||||||||||||
3'UTR of Stk32a (miRNA target sites are highlighted) |
>Stk32a|NM_178749|3'UTR 1 AGTGCTTCCGAGTCTTCGGGGGACAGTGCTTCGGGGGACAGTTCTTGGCACCTGGCGGGAAAGTCCTGATTATCACACAC 81 AGAAGAGCTGACAGGAGTCCCTGCCACTGCCACACCTCATGACTTAGAGAATATGAATGAGTAGTCTTCGAAGTTGGTGG 161 CAGCACTCTGCAGCGACAGGAGAGGAAGAGAGCCCTGGTTCTGAGCTCTTCAGTTCCAGCTTCAGCACGCATTGACTCTG 241 TGACCTTAAGTGAATCATTTAACTGCTTCCTCTGTTTTAGTTCACCGCTTGGAAGGTAGAGGGATATTTCAGGAGAGCTA 321 CTCTTTGCTCTGGCTACAGATTGCTCTAAACAGCCTTTATTCTTATTTTTAAATGAATATTTGAATGTAGATTTATTTTT 401 TATTCTTTCTGATGACACTGTGAAACATGGACACTGTACATAGTGGGCCTCTTCAGGGCTAGAGAATATCACACAGGGGC 481 CAGAATTCCAAAGCTTGATTAGGTAGGAATAAAGATGTTCCATCGGGAATAAATACATAGGTTAGATTAGAAGTAGCAAA 561 GACTCATGAGATCTTGAAGTGGGGAACTGGATGGGCACGGAATCTGTTTGCAAGTGCCTACTATGTGCATGGCCTCTCAC 641 GCTCTCTTGTGTGAGGTGGCCTTGATCAGTTAAACTTGATTCTGATGAGAGGAGTCATATGCAGAAGTTTAGCAAATGCT 721 GGGAGTTGGGACACATTTTTTTTTTTCCAACATGGCAGTTGTAAAATATCAGACTCTGGTATGTTTGTCCCTTGAAGGCT 801 AATTTTCCTCAAGGTTAGCAGAGACCTGCTTCTCCAGAGGATCAGAGAGTACTCCTGAACTACAGGTAGAGTTACTTGGA 881 ACTATTCAGTGAAGTCACACCTCACAGGAGAGATTTCCAGGAGTTTTGGAAGCAAGCAAACTTTCCCTTGAAACTCCTAA 961 CTCTACAAAGTGAAGGGGGAAAAAAAGTCAGTTGCTTTTTTGTCAAGAAATATATCACGTCTTTGTGTTGTTTGGCTCTT 1041 TATTTTTTGTATTGGTTAACTAAAATAGGGAACAATTTACACATATCTACTCAAGAGTTACACTTAAAGAAGCAGGATGG 1121 CTTATAGATCCCAGAGGTCAAATTCAGGGAGACCGATGCCCCCACGTTATGTAATCACTGTGAGATGGCTGGCAGAATTG 1201 CCCTGCTGCTTAACATATTGTTGAAGTCTGACACTTTCTTGTCTGTGTATTTCACTCATGTGCAGAGTGTCAGTCACCTT 1281 AACTGTGTATGTGTTGTAACTGCCCTGTGCTCACGCATACAAGATCTTTGAAGAACTTCTTCGAGTGCCCCACTGGTGAC 1361 GCTAGGTAGAATCATGACGTAGGTGGCTTTACAAAGCATGTTTTCAACTCTTGGGGAAACCGAGGCCATTAATGGTATTC 1441 CTTATGGAGAGTACAGGCATAGCCATGGTGGCAGCAAGCTGGTCCAAGTGACCAGCTTGATTGATTGATATCATTTGGGA 1521 AAGGCAGACATGGAAGTAGAGGGTAGCTACTGGGGCAAGAAAGTTTGTGTCGAAAACAAGAGCTGAGGGTAAGACTGGCA 1601 TTTACAGTTCGCCAGATTCTGGCGTGGTTGGGACATAGTGCCTCTCTACTAAGAGCAAACACACACACACACACACACAC 1681 ACACACACGCACGCACGCACGCACGCACGCACACAAGCACGCACGCACGCACACGCACGCACGCATGCATGCACGCACAT 1761 GCACGCACACGCACGCACGCACGCCAGCACGTACACGCACACGCACATTTTTAAGAATCAAAACCCACCTCTTTTATTGA 1841 GCTCCTGTCTCTGAGGTTCTGTCTGACGTTTTATTTGTGACATTTTGGTCATATTCCATCACTGTTTATCTCAAAGCATC 1921 TGCCCTGACCTTCAGAGGGATGAATGGGTCAAACATAGCAACCCAGAGACGACTCGATTCTGCTCCCGGCTGATACCCCA 2001 CAAGTGTCAGGGACCACATGCATGCTCCAGTTTTTGCCTTTTGTTCTTCTGTATTGAAGACCCAACGTGTTAGAGGTGTT 2081 ATGGATTTACCTGCCCTCACCTGGCCCCACCTTCTCCTGGACCTTGCCTGCATCCTCCAAAACAGCAGCTTTCAAATCGT 2161 TCTAAAGGCCAGCAGGGCCAGCAGGTCTCAAGTTCAAATCTCTAGTTTTTCTTCCCAGTGGGCATCTTTCTGAGCACGGT 2241 TGCTTTCAGAACTGGGGATATGCTGGTGAAAGTGCAGGGTGGGAGGTGGGTCAATGACAGGCACACCGTGTGTGGTCAGT 2321 TAAAAGG Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | C2C12 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1385343. RNA binding protein: 聽AGO2. Condition:C2C12_DM_Ago2_CLIP-Seq_myotubes
... - Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al., 2014, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al. - Cell, 2014
MicroRNAs are well known to mediate translational repression and mRNA degradation in the cytoplasm. Various microRNAs have also been detected in membrane-compartmentalized organelles, but the functional significance has remained elusive. Here, we report that miR-1, a microRNA specifically induced during myogenesis, efficiently enters the mitochondria where it unexpectedly stimulates, rather than represses, the translation of specific mitochondrial genome-encoded transcripts. We show that this positive effect requires specific miR:mRNA base-pairing and Ago2, but not its functional partner GW182, which is excluded from the mitochondria. We provide evidence for the direct action of Ago2 in mitochondrial translation by crosslinking immunoprecipitation coupled with deep sequencing (CLIP-seq), functional rescue with mitochondria-targeted Ago2, and selective inhibition of the microRNA machinery in the cytoplasm. These findings unveil a positive function of microRNA in mitochondrial translation and suggest a highly coordinated myogenic program via miR-1-mediated translational stimulation in the mitochondria and repression in the cytoplasm.
LinkOut: [PMID: 25083871]
|
56 mmu-miR-181b-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT004755 | Timp3 | tissue inhibitor of metalloproteinase 3 | 4 | 1 | ||||||||
MIRT005296 | Aicda | activation-induced cytidine deaminase | 5 | 1 | ||||||||
MIRT005300 | Slc35d3 | solute carrier family 35, member D3 | 2 | 1 | ||||||||
MIRT005301 | Ak4 | adenylate kinase 4 | 2 | 1 | ||||||||
MIRT005302 | Ndrg1 | N-myc downstream regulated gene 1 | 2 | 1 | ||||||||
MIRT005303 | Pitpnc1 | phosphatidylinositol transfer protein, cytoplasmic 1 | 2 | 1 | ||||||||
MIRT005304 | Tmem14a | transmembrane protein 14A | 2 | 1 | ||||||||
MIRT005305 | Cd244 | CD244 natural killer cell receptor 2B4 | 2 | 1 | ||||||||
MIRT005306 | Gch1 | GTP cyclohydrolase 1 | 2 | 1 | ||||||||
MIRT005307 | Errfi1 | ERBB receptor feedback inhibitor 1 | 2 | 1 | ||||||||
MIRT005308 | Hk2 | hexokinase 2 | 2 | 1 | ||||||||
MIRT005309 | Mxi1 | MAX interactor 1, dimerization protein | 2 | 1 | ||||||||
MIRT005310 | Ccdc58 | coiled-coil domain containing 58 | 2 | 1 | ||||||||
MIRT005311 | Sc4mol | methylsterol monoxygenase 1 | 2 | 1 | ||||||||
MIRT005312 | Pfkfb3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 2 | 1 | ||||||||
MIRT005313 | Pdxp | pyridoxal (pyridoxine, vitamin B6) phosphatase | 2 | 1 | ||||||||
MIRT005314 | Atp5g1 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9) | 2 | 1 | ||||||||
MIRT005315 | Casp3 | caspase 3 | 2 | 1 | ||||||||
MIRT005316 | Ulk3 | unc-51-like kinase 3 | 2 | 1 | ||||||||
MIRT005317 | Snx25 | sorting nexin 25 | 2 | 1 | ||||||||
MIRT005318 | Higd1a | HIG1 domain family, member 1A | 2 | 1 | ||||||||
MIRT006312 | Cbx7 | chromobox 7 | 2 | 1 | ||||||||
MIRT438370 | SIX2 | SIX homeobox 2 | 3 | 1 | ||||||||
MIRT438687 | Hspa5 | heat shock protein 5 | 3 | 1 | ||||||||
MIRT438688 | Uchl1 | ubiquitin carboxy-terminal hydrolase L1 | 3 | 1 | ||||||||
MIRT577184 | Smarca4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 1 | 5 | ||||||||
MIRT577425 | Tulp3 | tubby-like protein 3 | 1 | 1 | ||||||||
MIRT578325 | Magea5 | melanoma antigen, family A, 5 | 1 | 1 | ||||||||
MIRT579346 | Arhgef15 | Rho guanine nucleotide exchange factor (GEF) 15 | 1 | 4 | ||||||||
MIRT580671 | Stk32a | serine/threonine kinase 32A | 1 | 1 | ||||||||
MIRT580762 | Spp1 | secreted phosphoprotein 1 | 1 | 1 | ||||||||
MIRT581071 | Sgpp1 | sphingosine-1-phosphate phosphatase 1 | 1 | 1 | ||||||||
MIRT582047 | Osbpl3 | oxysterol binding protein-like 3 | 1 | 1 | ||||||||
MIRT582656 | Lnp | lunapark, ER junction formation factor | 1 | 2 | ||||||||
MIRT583661 | Fam160b2 | family with sequence similarity 160, member B2 | 1 | 5 | ||||||||
MIRT583691 | Fam122b | family with sequence similarity 122, member B | 1 | 1 | ||||||||
MIRT584580 | Bnc2 | basonuclin 2 | 1 | 1 | ||||||||
MIRT584878 | Ap1g1 | adaptor protein complex AP-1, gamma 1 subunit | 1 | 1 | ||||||||
MIRT586224 | Ptchd2 | dispatched RND transporter family member 3 | 1 | 2 | ||||||||
MIRT587223 | Fam69c | family with sequence similarity 69, member C | 1 | 1 | ||||||||
MIRT588616 | Trim2 | tripartite motif-containing 2 | 1 | 1 | ||||||||
MIRT589131 | Rad51d | RAD51 paralog D | 1 | 1 | ||||||||
MIRT589794 | Ikzf2 | IKAROS family zinc finger 2 | 1 | 2 | ||||||||
MIRT590593 | Atp2a2 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 | 1 | 1 | ||||||||
MIRT591186 | Ms4a4c | membrane-spanning 4-domains, subfamily A, member 4C | 1 | 3 | ||||||||
MIRT591489 | Aqp3 | aquaporin 3 | 1 | 2 | ||||||||
MIRT592858 | Adamts9 | a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9 | 1 | 2 | ||||||||
MIRT594856 | Nacc1 | nucleus accumbens associated 1, BEN and BTB (POZ) domain containing | 1 | 1 | ||||||||
MIRT594983 | Ebf3 | early B cell factor 3 | 1 | 1 | ||||||||
MIRT596592 | Zfp689 | zinc finger protein 689 | 1 | 1 | ||||||||
MIRT598537 | Itpk1 | inositol 1,3,4-triphosphate 5/6 kinase | 1 | 1 | ||||||||
MIRT598728 | H2-D1 | histocompatibility 2, D region locus 1 | 1 | 1 | ||||||||
MIRT600002 | 4930563E22Rik | RIKEN cDNA 4930563E22 gene | 1 | 1 | ||||||||
MIRT603966 | Gpd1l | glycerol-3-phosphate dehydrogenase 1-like | 1 | 1 | ||||||||
MIRT605134 | Clmn | calmin | 1 | 1 | ||||||||
MIRT606009 | Dagla | diacylglycerol lipase, alpha | 1 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|